DekaBank Deutsche Girozentrale - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2018. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2019$3,360,0000.0%1,200,0000.0%0.02%0.0%
Q3 2018$3,360,000
+50.0%
1,200,000
+71.4%
0.02%
+33.3%
Q2 2018$2,240,000700,0000.02%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Sterling Global Strategies LLC 21,940$71,0000.46%
Leisure Capital Management 157,301$503,0000.43%
BARD ASSOCIATES INC 759,000$2,430,0000.23%
Stonebridge Capital Advisors LLC 32,500$104,0000.02%
LEVEL FOUR ADVISORY SERVICES, LLC 63,500$203,0000.02%
DekaBank Deutsche Girozentrale 700,000$2,240,0000.02%
B. Riley Wealth Advisors, Inc. 21,350$69,0000.01%
Jacobi Capital Management LLC 7,421$24,0000.01%
Versant Capital Management, Inc 4,092$13,0000.01%
Cable Hill Partners, LLC 4,000$13,0000.01%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders